Ex vivo lung evaluation of prearrest heparinization in donation after cardiac death

Annals of Surgery

Volumn 257, Issue 3, 2013, Pages 534-541

  Sanchez, Pablo G ^a   Bittle, Gregory J ^a   Williams, Katrina ^a   Pasrija, Chetan ^a   Xu, Kai ^a   Wei, Xufeng ^a   Wu, Zhongjun J ^a   Griffith, Bartley P ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

donation after cardiac death; endothelial damage; ex vivo lung perfusion; heparin

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HEPARIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTRIC SHOCK; EX VIVO LUNG PERFUSION; EX VIVO STUDY; HEART DEATH; HEPARINIZATION; ISCHEMIA; LUNG; LUNG PERFUSION; LUNG TRANSPLANTATION; LUNG VASCULAR RESISTANCE; MALE; NONHUMAN; ORGAN DONOR; OXYGENATION; PRIORITY JOURNAL; ROOM TEMPERATURE; SWINE; TRACHEOBRONCHIAL TOILET;

ANIMALS; ANTICOAGULANTS; COLD ISCHEMIA; COLD TEMPERATURE; DISEASE MODELS, ANIMAL; HEART ARREST; HEPARIN; LUNG; LUNG TRANSPLANTATION; MALE; ORGAN PRESERVATION SOLUTIONS; PERFUSION; SWINE; TIME FACTORS; TISSUE DONORS; VASCULAR RESISTANCE; WARM ISCHEMIA;

EID: 84873993374     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e318273bef1     Document Type: Article

References (33)

1. Reich DJ, Mulligan DC, Abt PL, et al. ASTS recommended practice guidelines for controlled donation after cardiac death organ procurement and transplantation. Am J Transplant. 2009;9:2004-2011.
2. DuBois JM, Delmonico FL, D'Alessandro AM. When organ donors are still patients: is premortem use of heparin ethically acceptable? Am J Crit Care. 2007;16:396-400.
3. Puri V, Scavuzzo M, Guthrie T, et al. Lung transplantation and donation after cardiac death: a single center experience. Ann Thorac Surg. 2009;88:1609-1614; discussion 1614-1615.
4. Erasmus ME, Verschuuren EA, Nijkamp DM, et al. Lung transplantation from nonheparinized category III non-heart-beating donors. A single-centre report. Transplantation. 2010;89:452-457.
5. Rega FR, Neyrinck AP, Verleden GM, et al. How long can we preserve the pulmonary graft inside the nonheart-beating donor? Ann Thorac Surg. 2004;77:438-444; discussion 444.
6. Hayama M, Date H, Oto T, et al. Improved lung function bymeans of retrograde flush in canine lung transplantation with non-heart-beating donors. J Thorac Cardiovasc Surg. 2003;125:901-906.
7. Dark JH. Lung transplantation from the non-heart beating donor. Transplantation. 2008;86:200-201.
8. Nakamura T, Vollmar B, Winning J, et al. Heparin and the nonanticoagulant N-acetyl heparin attenuate capillary no-reflow after normothermic ischemia of the lung. Ann Thorac Surg. 2001;72:1183-1188; discussion 1188-1189.
9. Young E. The anti-inflammatory effects of heparin and related compounds. Thromb Res. 2008;122:743-752.
10. Kouretas PC, Kim YD, Cahill PA, et al. Heparin preserves nitric oxide activity in coronary endothelium during ischemia-reperfusion injury. Ann Thorac Surg. 1998;66:1210-1215.
11. Iba T, Takayama T. Enoxaparin attenuates endothelial damage with less bleeding compared with unfractionated heparin in endotoxemic rats. Shock. 2009;32:530-534.
12. CypelM, Yeung JC, Hirayama S, et al. Technique for prolonged normothermic ex vivo lung perfusion. J Heart Lung Transplant. 2008;27:1319-1325.
13. Steen S, Liao Q, Wierup PN, et al. Transplantation of lungs from nonheart-beating donors after functional assessment ex vivo. Ann Thorac Surg. 2003;76:244-252; discussion 252.
14. Xu KY. Activation of (Na+ + K+)-ATPase. Biochem Biophys Res Commun. 2005;338:1669-1677.
15. Li J, Hagner-McWhirter A, Kjellen L, et al. Biosynthesis of heparin/heparan sulfate. cDNA cloning and expression of D-glucuronyl C5-epimerase from bovine lung. J Biol Chem. 1997;272:28158-28163.
16. Salzman EW, Rosenberg RD, Smith MH, et al. Effect of heparin and heparin fractions on platelet aggregation. J Clin Invest. 1980;65:64-73.
17. Young E, Podor TJ, Venner T, et al. Induction of the acute-phase reaction increases heparin-binding proteins in plasma. Arterioscler Thromb Vasc Biol. 1997;17:1568-1574.
18. Weiler JM, Edens RE, Linhardt RJ, et al. Heparin and modified heparin inhibit complement activation in vivo. J Immunol. 1992;148:3210-3215.
19. Skinner MP, Lucas CM, Burns GF, et al. GMP-140 binding to neutrophils is inhibited by sulfated glycans. J Biol Chem. 1991;266:5371-5374.
20. Hecht I, Hershkoviz R, Shivtiel S, et al. Heparin-disaccharide affects T cells: inhibition of NF-kappaB activation, cell migration, and modulation of intracellular signaling. J Leukoc Biol. 2004;75:1139-1146.
21. Manduteanu I,VoineaM,Antohe F, et al. Effect of enoxaparin on high glucoseinduced activation of endothelial cells. Eur J Pharmacol. 2003;477:269-276.
22. Cypel M, Yeung JC, Liu M, et al. Normothermic ex vivo lung perfusion in clinical lung transplantation. N Engl J Med. 2011;364:1431-1440.
23. Lindstedt S, Hlebowicz J, Koul B, et al. Comparative outcome of double lung transplantation using conventional donor lungs and non-acceptable donor lungs reconditioned ex vivo. Interact Cardiovasc Thorac Surg. 2011;12:162-165.
24. Zych B, Popov AF, Stavri G, et al. Early outcomes of bilateral sequential single lung transplantation after ex-vivo lung evaluation and reconditioning [published online ahead of printNovember 16, 2011]. JHeart Lung Transplant. 2012;31:274-281.
25. Egan TM. Non-heart-beating donors in thoracic transplantation. J Heart Lung Transplant. 2004;23:3-10.
26. Van RaemdonckDE, JannisNC, De Leyn PR, et al.Warmischemic tolerance in collapsed pulmonary grafts is limited to 1 hour. Ann Surg. 1998;228:788-796.
27. Cicco G, Panzera PC, Catalano G, et al. Microcirculation and reperfusion injury in organ transplantation. Adv Exp Med Biol. 2005;566:363-373.
28. Lowe K, Alvarez DF, King JA, et al. Perivascular fluid cuffs decrease lung compliance by increasing tissue resistance. Crit Care Med. 2010;38:1458-1466.
29. Rega FR, Jannis NC, Verleden GM, et al. Long-term preservation with interim evaluation of lungs from a non-heart-beating donor after a warm ischemic interval of 90 minutes. Ann Surg. 2003;238:782-792; discussion 792-793.
30. Okazaki M, Date H, Inokawa H, et al. Optimal time for post-mortem heparinization in canine lung transplantation with non-heart-beating donors. J Heart Lung Transplant. 2006;25:454-460.
31. Rojas-Pena A, Hall CM, Cook KE, et al. Timing of heparin and perfusion temperature during procurement of organs with extracorporeal support in donors after circulatory determination of death. ASAIO J. 2011;57:368-374.
32. Kostering H, Mast WP, Kaethner T, et al. Blood coagulation studies in domestic pigs (Hanover breed) and minipigs (Goettingen breed). Lab Anim. 1983;17:346-349.
33. Kessler U, Grau T, Gronchi F, et al. Comparison of porcine and human coagulation by thromboelastometry. Thromb Res. 2011;128:477-482.